Educational Attainment, Aβ, Tau, and Structural Brain Reserve in Alzheimer's Disease

Overview

Journal Alzheimers Dement

Date 2025 Jan 24

PMID 39854134

Authors

Yue Cai

Lili Fang

Anqi Li

Jie Yang

Xin Zhou

Zhengbo He

Pan Sun

Qingyong Wang

Tengfei Guo

Affiliations

Soon will be listed here.

Abstract

Introduction: Alzheimer's disease (AD) patients with higher educational attainment (EA) often exhibit better cognitive function. However, the relationship among EA status, AD pathology, structural brain reserve, and cognitive decline requires further investigation.

Methods: We compared cognitive performance across different amyloid beta (Aβ) positron emission tomography (A ±) statuses and EA levels (High EA/Low EA). We examined the effects of Aβ plaques, tau tangles, and gray matter volume (GMV) on the relationship between EA and domain-specific cognitive decline.

Results: A+/High-EA individuals exhibited slower cognitive decline in global cognition and language domains than A+/Low-EA individuals. This cognitive benefit was independently and synergistically explained by reduced AD pathology, including lower Aβ and tau burdens, as well as preserved GMV. Additionally, High-EA individuals experienced a median delay of 1.9 years in the onset of significant brain atrophy among A+ individuals.

Discussion: These findings highlight the independent and synergistic contributions of EA-associated AD pathology and GMV alterations to longitudinal cognitive decline.

Highlights: Alzheimer's disease (AD) individuals with high educational attainment (EA) show slower declines in global cognition and language. EA-related slower cognitive decline is linked to reduced tau and greater gray matter volume in AD. AD individuals with high EA show a median 1.9 year delayed onset of brain atrophy.

Citing Articles

Educational attainment, Aβ, tau, and structural brain reserve in Alzheimer's disease.

Cai Y, Fang L, Li A, Yang J, Zhou X, He Z Alzheimers Dement. 2025; 21(2):e14400.

PMID: 39854134 PMC: 11848334. DOI: 10.1002/alz.14400.

References

Zha Z, Ploessl K, Choi S, Alexoff D, Kung H . Preclinical evaluation of [F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain. Nucl Med Biol. 2020; 92:97-106. DOI: 10.1016/j.nucmedbio.2020.03.003. View

Wolf D, Fischer F, Fellgiebel A . Impact of Resilience on the Association Between Amyloid-β and Longitudinal Cognitive Decline in Cognitively Healthy Older Adults. J Alzheimers Dis. 2019; 70(2):361-370. DOI: 10.3233/JAD-190370. View

Dolphin H, Dyer A, Morrison L, Shenkin S, Welsh T, Kennelly S . New horizons in the diagnosis and management of Alzheimer's Disease in older adults. Age Ageing. 2024; 53(2). PMC: 10859247. DOI: 10.1093/ageing/afae005. View

Ozyurek A . Hearing and seeing meaning in speech and gesture: insights from brain and behaviour. Philos Trans R Soc Lond B Biol Sci. 2014; 369(1651):20130296. PMC: 4123675. DOI: 10.1098/rstb.2013.0296. View

Guo T, Dukart J, Brendel M, Rominger A, Grimmer T, Yakushev I . Rate of β-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials. Alzheimers Dement. 2018; 14(11):1387-1396. DOI: 10.1016/j.jalz.2018.05.013. View

Hoenig M, Bischof G, Onur O, Kukolja J, Jessen F, Fliessbach K . Level of education mitigates the impact of tau pathology on neuronal function. Eur J Nucl Med Mol Imaging. 2019; 46(9):1787-1795. DOI: 10.1007/s00259-019-04342-3. View

Lovden M, Fratiglioni L, Glymour M, Lindenberger U, Tucker-Drob E . Education and Cognitive Functioning Across the Life Span. Psychol Sci Public Interest. 2020; 21(1):6-41. PMC: 7425377. DOI: 10.1177/1529100620920576. View

Mohajer B, Abbasi N, Mohammadi E, Khazaie H, Osorio R, Rosenzweig I . Gray matter volume and estimated brain age gap are not linked with sleep-disordered breathing. Hum Brain Mapp. 2020; 41(11):3034-3044. PMC: 7336142. DOI: 10.1002/hbm.24995. View

Papeo L, Agostini B, Lingnau A . The Large-Scale Organization of Gestures and Words in the Middle Temporal Gyrus. J Neurosci. 2019; 39(30):5966-5974. PMC: 6650980. DOI: 10.1523/JNEUROSCI.2668-18.2019. View

10.

Rzezak P, Squarzoni P, Duran F, de Toledo Ferraz Alves T, Tamashiro-Duran J, Bottino C . Relationship between Brain Age-Related Reduction in Gray Matter and Educational Attainment. PLoS One. 2015; 10(10):e0140945. PMC: 4608774. DOI: 10.1371/journal.pone.0140945. View

11.

Stern Y . Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012; 11(11):1006-12. PMC: 3507991. DOI: 10.1016/S1474-4422(12)70191-6. View

12.

Aizenstein H, Nebes R, Saxton J, Price J, Mathis C, Tsopelas N . Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008; 65(11):1509-17. PMC: 2636844. DOI: 10.1001/archneur.65.11.1509. View

13.

Dubois B, Epelbaum S, Nyasse F, Bakardjian H, Gagliardi G, Uspenskaya O . Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. Lancet Neurol. 2018; 17(4):335-346. DOI: 10.1016/S1474-4422(18)30029-2. View

14.

Jessen F, Amariglio R, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G . A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014; 10(6):844-52. PMC: 4317324. DOI: 10.1016/j.jalz.2014.01.001. View

15.

Amieva H, Mokri H, Le Goff M, Meillon C, Jacqmin-Gadda H, Foubert-Samier A . Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline. Brain. 2014; 137(Pt 4):1167-75. DOI: 10.1093/brain/awu035. View

16.

Guo T, Korman D, Baker S, Landau S, Jagust W . Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer's Disease Pathophysiology. Biol Psychiatry. 2020; 89(8):786-794. PMC: 9682985. DOI: 10.1016/j.biopsych.2020.06.029. View

17.

Scarmeas N, Stern Y . Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr Neurol Neurosci Rep. 2004; 4(5):374-80. PMC: 3026565. DOI: 10.1007/s11910-004-0084-7. View

18.

Li A, Zhao R, Zhang M, Sun P, Cai Y, Zhu L . [F]-D3FSP β-amyloid PET imaging in older adults and alzheimer's disease. Eur J Nucl Med Mol Imaging. 2024; 51(13):3990-4000. DOI: 10.1007/s00259-024-06835-2. View

19.

Lane C, Hardy J, Schott J . Alzheimer's disease. Eur J Neurol. 2017; 25(1):59-70. DOI: 10.1111/ene.13439. View

20.

Arenaza-Urquijo E, Vemuri P . Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies. Neurology. 2018; 90(15):695-703. PMC: 5894932. DOI: 10.1212/WNL.0000000000005303. View